로딩 중…
지수 로딩 중…
YUHAN CORPORATION
000100· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩76,100-2.69%
2026-06-19
Price Chart
YUHAN CORPORATION-24.73%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 6.06T KRW |
| Revenue | 2.22T KRW |
| Net Income | 208.62B KRW |
| Total Assets | 3.28T KRW |
| Net Assets | 2.34T KRW |
| Employees | 2,117 |
| Value | |
| P/E | 29.05x |
| P/B | 2.59x |
| PEG | 0.18x |
| P/S | 2.73x |
| EV/EBITDA | 211.66x |
| FCF Yield | 0.11% |
| Profitability | |
| ROE | 8.91% |
| ROA | 6.37% |
| Op. Margin | 4.81% |
| Revenue Growth | 7.16% |
| Earnings Growth | 164.72% |
| Financial Health | |
| Debt Ratio | 40.03% |
| Total Debt | 354.82B KRW |
| FCF | 6.63B KRW |
| Cash | 388.91B KRW |
| Current Ratio | 2.03x |
| Net Debt/EBITDA | -1.20x |
| Dividend | |
| Div. Yield | 0.77% |
| Div. Growth | 20.00% |
| Performance | |
| 1Y Return | -24.73% |
| 1M Return | -6.63% |
| From 52W High | -44.21% |
| 1Y MDD | -46.69% |
| Trading | |
| Volume | 393,824 shares |
| Foreign Own. | 18.64% |
| Per Share | |
| EPS | 2,617 KRW |
| BPS | 30,611 KRW |
Company Info
Established in 1926 and listed on the securities market in 1962, the company is a leading pharmaceutical firm, with 14 companies under its umbrella, including a subsidiary slated for KOSDAQ listing in 2025. Its primary business is the manufacturing and sale of pharmaceuticals and chemical products, including key products like Leclaza. The company is building an innovative network by adopting AI and big data for new drug development, collaborating with global pharmaceutical companies, and conducting joint R&D with bio-ventures and universities. The company is headquartered in Dongjak-gu, Seoul.